Literature DB >> 14556260

HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.

Akihiro Tamori1, Shuhei Nishiguchi, Shoji Kubo, Takashi Narimatsu, Daiki Habu, Tadashi Takeda, Kazuhiro Hirohashi, Susumu Shiomi.   

Abstract

Few studies have examined the etiology of hepatocellular carcinoma (HCC) in patients without hepatitis virus infection. We evaluated the role of occult hepatitis B virus (HBV) infection in the development of HCC in Japanese patients without hepatitis B surface antigen (HBsAg) and antibodies to hepatitis C antigen (anti-HCV). Twenty-one HBsAg negative and anti-HCV negative (non-B, non-C) patients with HCC were studied. HBV DNA in serum and HBV transcripts in liver were examined by polymerase chain reaction (PCR) or reverse transcription and PCR. HBV DNA integration was examined by Southern blot analysis or cassette-ligation-mediated PCR as described previously. p53 mutations were examined by direct sequencing. HBV DNA was not detected in serum from any patients. HBV-related transcripts were detected in 5 of 7 HCCs from patients with antibodies to hepatitis core antigen (anti-HBc) and in 3 of 14 HCCs from patients without anti-HBc (P = 0.0261). HBV DNA was integrated into human genome in two non-B, non-C HCCs. Of the 14 patients without anti-HBc, 5 had a history of excessive alcohol intake. In exons 5 through 8 of the p53 gene, mutations were detected in 2 of 8 HCCs with HBV-transcripts and in 5 of 13 HCCs without such transcripts. p53 mutation at codon 159 was found in 2 of 6 patients with excessive alcohol intake without HBV-transcripts. These results suggested that occult HBV infection might play an important role in hepatocarcinogenesis in non-B, non-C patients with anti-HBc and that excessive alcohol intake might be related to HCC in non-B, non-C patients in Japan. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556260     DOI: 10.1002/jmv.10514

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  17 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Differences in cause-of-death patterns between the native Dutch and persons of Indonesian descent in the Netherlands.

Authors:  Lintje Ho; Vivian Bos; Anton E Kunst
Journal:  Am J Public Health       Date:  2007-07-31       Impact factor: 9.308

3.  Hepatocellular carcinoma (HCC) recurring 10 years after clearance of hepatitis B surface antigen and 20 years after resection of hepatitis B virus-related HCC.

Authors:  Hiroji Shinkawa; Takuya Nakai; Akihiro Tamori; Hiromu Tanaka; Shigekazu Takemura; Kazuki Ohba; Takahiro Uenishi; Masao Ogawa; Satoshi Yamamoto; Seikan Hai; Tsuyoshi Ichikawa; Shintaro Kodai; Kazuhiro Hirohashi; Kenichi Wakasa; Shoji Kubo
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

4.  Multicentric hepatocarcinogenesis at 6 and 13 years after sustained viral response to hepatitis C virus.

Authors:  Yoshimasa Hashimoto; Daisuke Miyaki; Eisuke Murakami; Yuko Nagaoki; Yuki Kimura; Azakami Takahiro; Yoshio Katamura; Tomokazu Kawaoka; Shintaro Takaki; Masataka Tsuge; Nobuhiko Hiraga; Akira Hiramatsu; Koji Waki; Michio Imamura; Hiroshi Aikata; Shoichi Takahashi; Koji Arihiro; Hideki Ohdan; Kazuaki Chayama
Journal:  Clin J Gastroenterol       Date:  2012-05-13

5.  ABO blood type, diabetes and risk of gastrointestinal cancer in northern China.

Authors:  Yan Gong; Yun-Sheng Yang; Xiao-Mei Zhang; Ming Su; Jean Wang; Jin-Dong Han; Ming-Zhou Guo
Journal:  World J Gastroenterol       Date:  2012-02-14       Impact factor: 5.742

Review 6.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

7.  Association between hepatitis B virus and pancreatic cancer.

Authors:  Manal M Hassan; Donghui Li; Adel S El-Deeb; Robert A Wolff; Melissa L Bondy; Marta Davila; James L Abbruzzese
Journal:  J Clin Oncol       Date:  2008-10-01       Impact factor: 44.544

8.  A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan.

Authors:  Atsunori Kusakabe; Yasuhito Tanaka; Etsuro Orito; Fuminaka Sugauchi; Fuat Kurbanov; Tomoyuki Sakamoto; Noboru Shinkai; Noboru Hirashima; Izumi Hasegawa; Tomoyoshi Ohno; Ryuzo Ueda; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2007-04-26       Impact factor: 7.527

9.  Alcohol consumption and recurrence of non-B or non-C hepatocellular carcinoma after hepatectomy: a propensity score analysis.

Authors:  Atsushi Kudo; Shinji Tanaka; Daisuke Ban; Satoshi Matsumura; Takumi Irie; Takanori Ochiai; Noriaki Nakamura; Shigeki Arii; Minoru Tanabe
Journal:  J Gastroenterol       Date:  2013-10-18       Impact factor: 7.527

10.  Anti-hepatitis B virus X protein in sera is one of the markers of development of liver cirrhosis and liver cancer mediated by HBV.

Authors:  Hang Zhang; Lian-Ying Wu; Shuai Zhang; Li-Yan Qiu; Nan Li; Xuan Zhang; Xue-Zhi Zhang; Chang-Liang Shan; Li-Hong Ye; Xiao-Dong Zhang
Journal:  J Biomed Biotechnol       Date:  2009-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.